Marius A. Mackenzie
Nijmegen, GE, Netherlands
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Bortezomib maintenance after R-CHOP, cytarabine and autologous stem cell transplantation in newly diagnosed patients with mantle cell lymphoma, results of a randomised phase II HOVON trial.
Journal: British journal of haematology
Published: November 24, 2019
Cytomorphology review of 100 newly diagnosed lower-risk MDS patients in the European LeukemiaNet MDS (EUMDS) registry reveals a high inter-observer concordance.
Journal: Annals of hematology
Published: February 28, 2017
Treatment of secondary central nervous system lymphoma with intrathecal rituximab, high-dose methotrexate, and R-DHAP followed by autologous stem cell transplantation: results of the HOVON 80 phase 2 study.
Journal: Hematological oncology
Published: October 29, 2015
Second international round robin for the quantification of serum non-transferrin-bound iron and labile plasma iron in patients with iron-overload disorders.
Journal: Haematologica
Published: July 23, 2015
Validation of the revised international prognostic scoring system (IPSS-R) in patients with lower-risk myelodysplastic syndromes: a report from the prospective European LeukaemiaNet MDS (EUMDS) registry.
Journal: British journal of haematology
Published: November 28, 2014
X-linked sideroblastic anaemia due to ALAS₂ mutations in the Netherlands: a disease in disguise.
Journal: The Netherlands journal of medicine
Published: May 16, 2014
A dominant-negative GFI1B mutation in the gray platelet syndrome.
Journal: The New England journal of medicine
Published: December 12, 2013
Showing 1-8 of 8
Last Updated: 09/26/2026